Literature DB >> 28740613

Synthesis and Biological Evaluation of Paclitaxel and Camptothecin Prodrugs on the Basis of 2-Nitroimidazole.

Chen Jin1, Shuai Wen1, Qiumeng Zhang1, Qiwen Zhu1, Jiahui Yu1, Wei Lu1.   

Abstract

Due to the low esterase activity in human plasma, many ester and carbonate prodrugs tested in humans may be less effective than that in preclinical animals. In this letter, PTX and SN-38 were attached to the N-1 position of 2-nitroimidazole via a carbonate linker. Presumably, 2-aminoimidazole may help promote the intramolecular hydrolysis of the carbonate bond. The prodrugs exhibited a considerable stability in buffers at different pH values as well as in human plasma. Furthermore, a rapid reduction was exhibited in the presence of nitroreductase. An in vitro cytotoxicity assay demonstrated that hypoxic conditions could increase the toxicity of prodrugs. Potentially, the compound species may form a new class of promising antitumor agents.

Entities:  

Keywords:  2-Nitroimidazole; SN-38; paclitaxel; prodrug

Year:  2017        PMID: 28740613      PMCID: PMC5512130          DOI: 10.1021/acsmedchemlett.7b00189

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

1.  Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivatives.

Authors:  Guillermo Rodriguez-Berna; Maria Jose Díaz Cabañas; Victor Mangas-Sanjuán; Marta Gonzalez-Alvarez; Isabel Gonzalez-Alvarez; Ibane Abasolo; Simó Schwartz; Marival Bermejo; Avelino Corma
Journal:  ACS Med Chem Lett       Date:  2013-05-28       Impact factor: 4.345

Review 2.  Paclitaxel in cancer therapy.

Authors:  Tarek M Mekhail; Maurie Markman
Journal:  Expert Opin Pharmacother       Date:  2002-06       Impact factor: 3.889

3.  Synthesis and Characterization of Cell-Permeable Oligonucleotides Bearing Reduction-Activated Protecting Groups on the Internucleotide Linkages.

Authors:  Hisao Saneyoshi; Koichi Iketani; Kazuhiko Kondo; Takeo Saneyoshi; Itaru Okamoto; Akira Ono
Journal:  Bioconjug Chem       Date:  2016-09-06       Impact factor: 4.774

Review 4.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

5.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

Authors:  R P Hertzberg; M J Caranfa; K G Holden; D R Jakas; G Gallagher; M R Mattern; S M Mong; J O Bartus; R K Johnson; W D Kingsbury
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

Review 6.  Advances in the use of taxanes in the adjuvant therapy of breast cancer.

Authors:  Jean-Marc Nabholtz; Jean-Michael Vannetzel; Jean-Francois Llory; Patrick Bouffette
Journal:  Clin Breast Cancer       Date:  2003-08       Impact factor: 3.225

Review 7.  Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.

Authors:  Caroline Wigerup; Sven Påhlman; Daniel Bexell
Journal:  Pharmacol Ther       Date:  2016-04-29       Impact factor: 12.310

8.  Species difference of esterase expression and hydrolase activity in plasma.

Authors:  Fatma Goksin Bahar; Kayoko Ohura; Takuo Ogihara; Teruko Imai
Journal:  J Pharm Sci       Date:  2012-07-25       Impact factor: 3.534

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker.

Authors:  Xuan Zhang; Kaiyong Tang; Hong Wang; Yaqian Liu; Bin Bao; Yanfen Fang; Xiongwen Zhang; Wei Lu
Journal:  Bioconjug Chem       Date:  2016-04-21       Impact factor: 4.774

View more
  2 in total

1.  PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment.

Authors:  Mohammad Irani; Sina Mohammadrezaei Nodeh
Journal:  RSC Adv       Date:  2022-06-01       Impact factor: 4.036

2.  Tetrazine-mediated bioorthogonal prodrug-prodrug activation.

Authors:  Kevin Neumann; Alessia Gambardella; Annamaria Lilienkampf; Mark Bradley
Journal:  Chem Sci       Date:  2018-07-12       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.